Drug Type Small molecule drug |
Synonyms- |
Action antagonists, inhibitors |
Mechanism D2 receptor antagonists(Dopamine D2 receptor antagonists), Proton pump inhibitors |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H24ClN5O2 |
InChIKeyFGXWKSZFVQUSTL-UHFFFAOYSA-N |
CAS Registry57808-66-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Gastroesophageal Reflux | Phase 3 | Turkey | 28 Nov 2017 |